英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
snede查看　snede　在百度字典中的解释百度英翻中〔查看〕
snede查看　snede　在Google字典中的解释Google英翻中〔查看〕
snede查看　snede　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Official Home Page of the Apellis Pharmaceuticals Corporate Site . . .
    Apellis is a global biopharmaceutical company that develops life-changing therapies By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology
  • About Apellis - Advancing Treatment by Inhibiting the Complement . . .
    Apellis is a global biopharmaceutical company that develops life-changing therapies By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology
  • Our Pipeline - Therapeutics for Ophthalmology, Hematology . . . - Apellis
    At Apellis, we aim to transform treatment across a broad range of debilitating diseases driven by complement We brought forward the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved across four diseases
  • Open Positions - Apellis
    Open Positions Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases Note to Employment Agencies: Please do not forward any agency resumes Apellis is not responsible for any fees related to resumes that are unsolicited
  • Our Products - Apellis
    Please see full Prescribing Information Patients and healthcare providers in the United States can learn more at: Syfovre com Comprehensive product support for patients EMPAVELI APELLIS ASSIST (866) 692-7527 SYFOVRE APELLIS ASSIST (888) 273-5547
  • Investors Media - Apellis Pharmaceuticals, Inc.
    Apellis Pharmaceuticals, Inc is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face
  • Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results
    Apellis Pharmaceuticals, Inc is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face
  • Executive Leadership Team at Apellis| Apellis Pharmaceuticals
    Meet the leadership team that guides development of targeted C3 therapies to inhibit diseases driven by excessive activation of the complement cascade The team possesses decades of experience across pharmaceutical R D, drug development, regulatory affairs, and business development
  • Career Opportunities and Benefit Programs | Apellis Pharmaceuticals
    We're committed to making Apellis a place where we love what we do and we're proud to be recognized as a top workplace “At Apellis, the contribution and help of every individual counts As a small but growing company, we offer a unique opportunity to grow while learning from each other
  • FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and . . .
    Apellis Pharmaceuticals, Inc is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face





中文字典-英文字典  2005-2009